Should I Buy ACGL? ACGL 2026 Analysis

Should You Buy Arch Capital Group Ltd (ACGL) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

100.950

1 Day change

-1.01%

52 Week Range

103.390

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient entry: price is extended/overbought and sitting just under near-term resistance (~97.07).
Trend is still bullish (strong MAs + positive MACD), so this is more of a hold / buy-the-dip setup than a chase.
Options positioning is modestly bullish (put/call < 1), but not strong enough to override the stretched technicals.
No fresh news catalyst this week; next meaningful catalyst is Q4 (QDEC 2025) earnings on 2026-02-09 AH.
Intellectia Proprietary Trading Signals
- AI Stock Picker: No signal on given stock today.
- SwingMax: No signal on given stock today.

Technical Analysis

Primary trend: Bullish (SMA_5 > SMA_20 > SMA_200) with positive momentum.
MACD: histogram +0.493 and expanding, supports continued uptrend.
RSI(6): 82.38 (overbought) → higher risk of a quick pullback/mean reversion.
Key levels: Pivot 94.28 (better dip-entry zone); Resistance 97.07 (R1) then 98.79 (R2); Support 91.49 (S1).
Short-horizon pattern stats provided: modest upside odds next day/week, but flat-to-slightly negative over the next month (suggests limited chase-up potential).

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Sentiment: Put/Call ratios below 1 = generally bullish/less hedging skew.
Activity: today’s option volume 136 vs 30-day avg participation indicator 54.18 (notable, but not a blowout).
Volatility: IV(30d) 27.6 vs Historical Vol 19.71 → options are priced rich (often seen when market expects moves; can also imply cautious positioning).
Positioning note: Open interest totals (calls 3588 vs puts 2638) lean call-heavy, consistent with mild bullish bias.

Technical Summary

Sell

Buy

Positive Catalysts

- Technical uptrend intact (bullish moving averages + positive MACD).
- Next catalyst: Earnings 2026-02-09 (After Hours) could re-rate shares if underwriting/investment income stays strong.
- Prior quarter showed strong profitability momentum (see financials), which can support continued buy-side interest.
- Options positioning mildly bullish (put/call ratios < 1).

Neutral/Negative Catalysts

- Near-term technical condition is stretched: RSI overbought and price near R1 resistance (~97.07) → higher risk of pullback right after entry.
- Sector backdrop (per multiple analysts): P&C cycle softening, more competition/capital supply → potential margin/growth headwinds.
- No supportive news flow in the last week to justify chasing strength.
- Trading trends: Hedge funds/insiders reported neutral (no strong “smart money” push visible in provided data).
- Political/congress activity: No recent congress trading data available (no confirmatory signal).

Financial Performance

Latest quarter: 2025/Q3.
Revenue: $4.856B (+5.84% YoY) → steady top-line growth.
Net Income: $1.34B (+37.01% YoY) → strong profitability acceleration.
EPS: 3.56 (+39.06% YoY) → earnings power improved materially.
Overall: fundamentals in the last reported quarter were strong, but forward narrative is more about cycle softening than backward-looking beats.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent changes show a cluster of price-target raises (Barclays to 104, Evercore to 100, JPMorgan to 117, KBW to 102, Morgan Stanley to 110), but ratings are largely Neutral/Market Perform/In Line.
Bears: Goldman Sachs maintained Sell (PT 93) citing underappreciated softening-cycle pressure.
Bulls: BofA kept Buy (PT 131) and RBC resumed Outperform (PT 108), emphasizing underwriting strength and investment income, though acknowledging slowing top-line.
Wall Street pros/cons summary:
- Pros: strong ROE/earnings execution, underwriting margins, investment income tailwind.
- Cons: softening pricing cycle, tougher catastrophe comps, reserving uncertainty, and potential margin/growth deceleration.
Net takeaway: Street view is selectively constructive but cautious—not a clear consensus “buy-it-now” setup at this exact price/technical stretch.

13 Analyst Rating

Wall Street analysts forecast ACGL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACGL is 107.62 USD with a low forecast of 93 USD and a high forecast of 131 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

6 Buy

6 Hold

1 Sell

Moderate Buy

Current: 101.980

Low

Averages

107.62

High

131

Current: 101.980

Low

Averages

107.62

High

131

Barclays

Alex Scott

Equal Weight

maintain

$99 -> $104

AI Analysis

2026-01-08

Reason

Barclays

Alex Scott

Price Target

$99 -> $104

AI Analysis

2026-01-08

maintain

Equal Weight

Reason

Barclays analyst Alex Scott raised the firm's price target on Arch Capital to $104 from $99 and keeps an Equal Weight rating on the shares. The firm adjusted ratings and price targets as part of its 2026 outlook for the North America property and casualty Insurance group. Pricing is softening across commercial and reinsurance, while personal lines look relatively better and brokers face organic growth headwinds, the analyst tells investors in a research note. Barclays recommends staying selective.

Evercore ISI

David Motemaden

In Line

maintain

$97 -> $100

2026-01-07

Reason

Evercore ISI

David Motemaden

Price Target

$97 -> $100

2026-01-07

maintain

In Line

Reason

Evercore ISI analyst David Motemaden raised the firm's price target on Arch Capital to $100 from $97 and keeps an In Line rating on the shares. With a tough cyclical backdrop, 2026 is "shaping up to be a challenging year for the P&C insurance sector," but this presents "a stock pickers market with opportunities for discerning investors," the analyst says in a year-ahead outlook note for the group.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ACGL

Unlock Now

ACGL Should I Buy

ACGL Should I Buy

Should You Buy Arch Capital Group Ltd (ACGL) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch